Mandorfer, Mattias <br/><br/>
Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy.  [electronic resource] 

 -  Antiviral therapy  2014 
 - 407-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>2040-2058 
<br/><br/><label>Standard No.: </label>10.3851/IMP2717  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiretroviral Therapy, Highly Active<br/>Antiviral Agents--therapeutic use<br/>CD4 Lymphocyte Count<br/>Coinfection<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>HIV Infections--drug therapy<br/>HIV-1--genetics<br/>Hepacivirus--genetics<br/>Hepatitis C--complications<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Interferons<br/>Interleukins--genetics<br/>Liver Cirrhosis--etiology<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Polyethylene Glycols--therapeutic use<br/>Recombinant Proteins--therapeutic use<br/>Retrospective Studies<br/>Treatment Failure<br/>Treatment Outcome<br/>Viral Load<br/>Young Adult